Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Tudor Investment Corporation »

Inhibrx Biosciences shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download consolidated filings csv

Download as Excel

Download consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Tudor Investment Corporation

Quarter filed	Position value	Share count	Share price at filing
2026-03-31	$496k	7.4k	67.23
2025-12-31	$367k	4.6k	79.00

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)

Invesco Qqq Trust Series 1 - US ETP ETF Option Call Option (QQQ)

State Street SPDR S&P 500 ETF Trust - US ETP ETF Option Call Option (SPY)

Spdr Gold Shares - US ETP ETF Option Call Option (GLD)

Nvidia Corp - US Equity (NVDA)

State Street Energy Select Sector SPDR ETF - US ET ETF Option Call Option (XLE)

Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)

Microsoft Corp - US Equity (MSFT)

State Street Financial Select Sector SPDR ETF - US ETF Option Call Option (XLF)

Tesla Inc - US Equity (TSLA)

Ishares China Large-Cap Etf - US ETP ETF Option Call Option (FXI)

Meta Platforms Inc - US Equity (META)

Taiwan Semiconductor Manufacturing Co Ltd - US Depository Receipt (TSM)

Alibaba Group Holding Ltd - US Depository Receipt (BABA)

Amazon.Com Inc - US Equity (AMZN)

View all positions for Tudor Investment Corporation

Top funds holding Inhibrx Biosciences

Perceptive Advisors

Viking Global Investors

HighTower Advisors

Susquehanna International

State Street Corporation

Vanguard Capital Management

Caligan Partners

Sofinnova Ventures

Capital Research Global Investors

Woodline Partners

Millennium Management

View all funds holding Inhibrx Biosciences

© 2026 stockzoa - Track 13F-HR Filings for Hedge Funds and Value Investors.

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z